HomeLatest NewsFederal NewsHRSA Determines 6 Pharmaceutical Manufacturers Violated 340B Program

HRSA Determines 6 Pharmaceutical Manufacturers Violated 340B Program

​Health Resources and Services Administration (HRSA) Acting Administrator Diana Espinosa sent letters to six pharmaceutical manufacturers stating that HRSA determined that their policies placing restrictions on 340B Program pricing to covered entities that dispense medications through contract pharmacies resulted in overcharges and are in direct violation of the 340B statute.

Beginning in July 2020, the manufacturers began taking specific actions that limited covered entity’s access to discounted drugs available for purchase under the 340B Program. Some manufacturers stopped providing the 340B ceiling price on their drug products sold to covered entities and dispensed through contract pharmacies, while others limited sales by requiring specific data submissions or selling drug products only after a covered entity demonstrated 340B compliance. HRSA conducted a review of these actions and an analysis of complaints received from covered entities, resulting in the letters sent by HRSA.

The 340B Program Ceiling Price and Civil Monetary Penalties final rule states that any manufacturer participating in the 340B Program that knowingly and intentionally charges a covered entity more than the ceiling price for a covered outpatient drug may be subject to a Civil Monetary Penalty (CMP) not to exceed $5,000 for each instance of overcharging. Assessed CMPs would be in addition to repayment for an instance of overcharging.The full text of the letters can be found on the HRSA Program Integrity page.

Stay Connected

Unified Voice Newsletter

Events This Month


30may11:00 am12:00 pmWorkplace Violence Prevention and Response StrategiesSDAHO Webinar


31may12:00 pm1:00 pmResidents with a Schizophrenia Diagnosis: Now What?SDAHO Webinar

31mayAll Day01junMission Possible | Reducing the Impact of Substance Abuse + Mental Illness

By submitting this form, you are consenting to receive marketing emails from: SDAHO, 3708 W Brooks Place, Sioux Falls, SD, 57106, http://sdaho.org. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact